Literature DB >> 36213600

Actinobacillus suis isolated from diseased pigs are phylogenetically related but harbour different number of toxin gene copies in their genomes.

Dharmasiri Gamage Ruwini Sulochana Kulathunga1, Alaa Abou Fakher2, Matheus de Oliveira Costa1,2.   

Abstract

Objective: The Gram-negative bacterium Actinobacillus suis is an agent of global importance to the swine industry and the cause of lethal respiratory or septicaemic disease in pigs of different ages. Between 2018 and 2019, seven commercial farms in western Canada experienced episodes of increased mortality due to A. suis infection in grower pigs. The goal of this work was to profile, with molecular methods, A. suis isolated from diseased pigs and to compare them to other isolates. Design: This inferential observational study used nine western Canadian strains obtained from diseased lungs (n = 6), heart (n = 2) and brain (n = 1) and whole genome sequencing was performed. Comparative genomic analyses were performed to characterise the genetic variability, antimicrobial resistance and the virulence genes present.
Results: Compared to the reference strain (ATCC 33415), an increased number of RTX (repeats in the structural toxin) gene copies were identified in strains isolated from organs without a mucosal surface, thus theoretically harder to invade. Western Canadian strains did not harbour genes associated with resistance to antimicrobial agents used in swine production. Novel regions were also identified in the genomes of five of nine strains demonstrating recombination and emergence of novel strains. Conclusions: The results obtained in this study were associated with the emergence of new lineages. An increased number of RTX toxin gene copies is suggested to be associated with increased virulence. This study will contribute to improve our understanding regarding A. suis and may help guide vaccine development and agent control measures.
© 2022 The Authors. Veterinary Record Open published by John Wiley & Sons Ltd on behalf of British Veterinary Association.

Entities:  

Year:  2022        PMID: 36213600      PMCID: PMC9528957          DOI: 10.1002/vro2.45

Source DB:  PubMed          Journal:  Vet Rec Open        ISSN: 2052-6113


INTRODUCTION

Actinobacillus suis is a facultative anaerobic, non‐motile, Gram‐negative bacillus. It is an important pathogen of swine, leading to respiratory disease or septicaemia in pigs of different ages and stages of production. , The organism was first identified and described in 1955, when it was associated with acute septicaemia and sudden death in domestic swine. Actinobacillus suis colonises the nasopharynx and palatine tonsils of healthy pigs; it is a commensal. It can also colonise the vaginal mucosa of healthy sows. Disease is often associated with stressful conditions such as weaning, farrowing, transportation or suckling. , Weaned pigs often do not develop clinical signs and are found dead following fulminant septicaemia, while grower‐finisher or older pigs in high‐health status (HHS) herds develop respiratory signs due to necro‐haemorrhagic pleuropneumonia. , , A third syndrome observed in HHS reproductive‐aged pigs is characterised by acute septicaemia, lethargy, anorexia, fever, abortion and erysipelas‐like lesions on the skin. Treatment strategies include parenteral antimicrobial therapy with ceftiofur, penicillin, ampicillin, neomycin, gentamicin, sulphadimethoxine, tiamulin, tetracycline or tylosin. However, variation in sensitivity to antimicrobial therapy has been reported and antimicrobial susceptibility testing is suggested when clinical cases are identified. Autogenous bacterins have been used to prevent disease and shown variable results. These evidence a gap in our understanding of A. suis pathogenesis, contributing to our inability in developing efficient prevention, treatment and control tools. Actinobacillus suis can be readily isolated using blood and McConkey media, producing β‐haemolytic smooth, translucent colonies. Genes belonging to different functional classes have been proposed to contribute to virulence and facilitate colonisation of mucosal sites. , A previous study described 13 virulence genes in A. suis, identified using genome‐wide screening by PCR‐based signature‐tagged transposon mutagenesis. Noteworthy is the RTX (repeats in the structural toxin) gene family. It encodes a pore‐producing protein and is proposed as a disease determinant associated with A. suis. The RTX genes identified in A. suis is immunologically and genetically related to the RTX genes described in other pathogenic bacteria such as Escherichia coli, Pasteurella haemolytica and Actinobacillus pleuropneumoniae. Sporadic outbreaks of A. suis were previously reported in Canada, the United States, UK, India, New Zealand, Hungary, Croatia and Australia. , Since 1990, an increasing number of clinical disease outbreaks have been reported in pigs of varying ages in North America and considered as an emerging disease. , , Therefore, the purpose of this study was to investigate the molecular epidemiology, virulence and antimicrobial gene profile in A. suis isolated from diseased pigs in western Canada.

MATERIAL AND METHODS

Bacterial strains

Between 2017 and 2019, clinical samples (n = 9) were collected from pigs with signs suggestive of A. suis infection in seven commercial farms in western Canada. Isolates were obtained from lungs (n = 6), heart (n = 2) and brain (n = 1) (Table 1). Samples were streaked on 5% blood agar and incubated at 37°C under aerobic conditions and plates were examined at 24 and 48 h for growth. Matrix‐assisted laser desorption/ionisation‐time of flight was performed for initial identification; colonies identified as A. suis were selected and saved for further genomic analysis.
TABLE 1

Metadata associated with Actinobacillus suis western Canadian strains obtained from diseased pigs

Strain IDSource organPostmortem diagnosisCollection locationCollection date
20_277_1aHeartSepticaemiaFarm 6June 2020
20_377_1aBrainSepticaemiaFarm 7April 2020
17_471LungBronchopneumoniaFarm 1September 2017
4286LungBronchopneumoniaFarm 2October 2018
19_419LungBronchopneumoniaFarm 3September 2019
19_418LungBronchopneumoniaFarm 3September 2019
19_298HeartBronchopneumonia/septicaemiaFarm 4June 2019
18_466LungBronchointerstitial pneumoniaFarm 5October 2018
18_292LungBronchopneumoniaFarm 6June 2019
Metadata associated with Actinobacillus suis western Canadian strains obtained from diseased pigs

Genome sequencing and assembly

Genomic DNA from isolates was extracted using DNeasy ultraclean microbial kit (QIAGEN, Toronto, Ontario, Canada). Sequencing libraries for isolates 19_419, 19_418, 18_466, 19_298, 18_292, 4286 and 17_417 were prepared using the Nextera XT DNA library (Illumina, San Diego, CA, USA) preparation kit according to the manufacturer's instructions. Library quality was assessed using bioanalyser (Agilent Technologies, Santa Clara, CA, USA) and sequencing was performed using an Illumina MiSeq Platform (Illumina Inc., 500 cycles, 2 × 250) and MiSeq V3 reagent kits (Illumina Inc.). Isolates 20_377_1a and 20_277_1a had DNA libraries prepared using a Rapid Sequencing Kit (SQK‐RAD0003, Oxford Nanopore Technologies, Oxford, UK). Libraries were sequenced on a MinION sequenced (Oxford Nanopore Technologies) using a Flow Cell model FLO‐MIN 106 v R9.4 running the software MinKNOWN v1.10 (Oxford Nanopore Technologies) with default parameters. Genomes were trimmed, assembled, annotated and analysed using the comprehensive genomic analysis tool in Pathosystem Resource Integration Center (PATRIC).

Phylogenetic tree of Actinobacillosis suis and whole genome comparisons

Three complete and four draft A. suis genomes isolated from pigs with clinical disease suggestive of A. suis infection were included in these analyses, as well as A. pleuropneumoniae strain NCTC 10976, which was included in the analysis as an outgroup. These were initially identified between 1963 and 1991 in North America; they were retrieved from National Center for Biotechnology Information (www.ncbi.nlm.nih.gov) (Table 2). Randomised accelerated maximum likelihood for high‐performance computing (RAxML‐VI‐HPC) in PATRIC using 500 genes and allowing neither deletions nor duplications was used to build the phylogenetic tree. Orthologous average nucleotide identity was performed to measure the overall similarity between genome sequences using OrthoANI V0.93.1 available at EzBioCloud. Protein sequences of all western Canadian strains were compared to the reference genome ATCC 33415 using bidirectional BLASTP with parameters set to minimum coverage = 30%, minimum identity = 10% and BLAST E‐value = 1e‐5 and a circular genomic map was constructed. , Progressive Mauve was used to reorder contigs and align query genomes to ATCC 33415 to identify homologous regions distribution. ,
TABLE 2

Publicly available Actinobacillus suis genomes used for comparison with western Canadian strains

Strain IDSerovarCountry, province of originIsolation sourceCollection yearReference
ATCC 33415O1:K1USAPig with septicaemiaNot available 19
ATCC 15557O1:K1USA, Washington DCBlood of irradiated adult pig1963 20
NCTC 12996Not availableNot availablePig with septicaemia1980NCBI
AS108/13Not availableBrazil, Minas GeraisPig with pneumonia2013 21
H89‐1173O2:K3Canada, OntarioLung of pig with pneumonia1989 22
H91‐0380O2:K2Canada, OntarioPig with septicaemia1991 23
H91‐0406O2:K3Canada, OntarioLung of pig with pneumonia1991 22

Abbreviation: NCBI, National Center for Biotechnology Information.

Publicly available Actinobacillus suis genomes used for comparison with western Canadian strains Abbreviation: NCBI, National Center for Biotechnology Information.

Functional characterisation

Genomes were screened for the presence of virulence factors using BLASTP. , , Antimicrobial resistance genes (ARG) in all A. suis genomes were identified using the Resistance Gene Identifier platform and the Comprehensive Antimicrobial Resistance Database, only genes with greater than 80% identity were reported. ,

RESULTS

Whole genome comparisons and phylogenetic analysis

A summary of the A. suis genomes used in this study is listed in Table 3. Average genomic length and number of genes identified were numerically higher in the seven genomes from this study (2.52 ± 0.4 Mbp and 2478 ± 173 genes) when compared to publicly available genomes (2.48 ± 0.6 Mbp and 2328 ± 107 genes). Average nucleotide identity (ANI) scores for all pairwise comparisons, including previously published genomes, were greater than 99% (Table 4). Noteworthy, isolates 18_466, 18_292, 19_419, 19_418, 17_471, H91‐0406 and H91‐0380 came from different barns and were 99.9% similar to H89‐1173, which was isolated from a diseased pig in Ontario (in 1989). Multiple genome alignment identified a genomic region present in strains ATCC 33415, 17_471 and AS108/13; this was absent in strains 4286, ATCC 15557, H89‐1173, H91‐0380, H91‐0406, 19_298, 20_277_1a and 20_377_1a (Figure 1, yellow region at approximately 1 Mbp). Strain AS108/13 was also noted to have two strain‐specific regions at approximately 0.5 and 1.2 Mbp (Figure 1).
TABLE 3

Summary of Actinobacillus suis genomes included in in silico analyses

Strain IDSourceGenome accessionContigsGC content (%)Sequence length (bp)# Genes identified
20_277_1aThis studyCP090556 a 240.2625491822775
20_377_1aThis studyJAKEZJ000000000140.2325514162772
17_471This studySAMN244514963740.0825338342416
4286This studyJAKEZI0000000002940.1624565812320
19_419This studyJAJUOY0000000002940.0925346522414
19_418This studySAMN244515003040.0925349212412
19_298This studyJAJUOZ0000000002940.1624539992319
18_466This studySAMN244514983040.1425693702467
18_292This studyJAJUPA0000000002840.0925360932416
ATCC 33415PublicCP009159140.2225015982341
ATCC 15557PublicNZ_MTBV000000008040.2224095792179
NCTC 12996PublicNZ_LT906456.1140.2225019592338
H91‐0380PublicCP003875240.2424849402249
AS108/13PublicQCXP014440.1726177982528
H89‐1173PublicNZ_MTBW000000007440.2324508992345
H91‐0460PublicNZ_MTBX0000000011640.3524235002318

BioProject ID PRJNA792721.

TABLE 4

Average nucleotide identity (%) between clinical (this study) and publicly available Actinobacillus suis genomes

Strain ID20_377_1a18_292ATCC 33415ATCC 1555720_277_1aNCTC 12996AS108/1318_46617_471H89‐1173H91‐038012_298H91‐046019_49119_4184286
20_377_1a*99.7899.7599.6399.8399.7599.8799.7899.7799.8299.8199.6599.8499.7899.7899.96
18_29299.78*99.7599.6899.7999.7599.4210099.9999.9399.9199.7399.9210010099.82
ATCC 3341599.7599.75*99.7499.7510099.4699.7599.7499.899.7899.5899.8199.7599.7599.8
ATCC 1555799.6399.6899.74*99.6999.7799.7799.6999.6899.7599.7299.5199.7499.6999.6999.73
20_277_1a99.8399.7999.7599.69*99.7699.8799.899.7999.8499.8399.7599.8599.899.899.83
NCTC 1299699.7599.7510099.7799.76*99.4499.7599.7599.7899.7799.5799.899.7599.7599.78
AS108/1399.8799.4299.4699.7799.8799.44*99.1999.1899.8999.8899.799.999.1899.1899.91
18_46699.7810099.7599.6999.899.7599.19*99.9799.9499.9299.7399.9499.9899.9899.83
17_47199.7799.9999.7499.6899.7999.7599.1899.97*99.9299.999.7199.9210010099.82
H89‐117399.8299.9399.899.7599.8499.7899.8999.9499.92*99.9899.7999.9999.9399.9399.89
H91‐038099.8199.9199.7899.7299.8399.7799.8899.9299.999.98*99.7799.9899.9299.9299.87
12_29899.6599.7399.5899.5199.7599.5799.799.7399.7199.7999.77*99.7899.7299.7299.68
H91‐046099.8499.9299.8199.7499.8599.899.999.9499.9299.9999.9899.78*99.9299.9299.88
19_49199.7810099.7599.6999.899.7599.1899.9810099.9399.9299.7299.92*10099.84
19_41899.7810099.7599.6999.899.7599.1899.9810099.9399.9299.7299.92100*99.84
428699.9699.8299.899.7399.8399.7899.9199.8399.8299.8999.8799.6899.8899.8499.84*
FIGURE 1

Multiple genome alignment across all strains used in this study. Blocks with the same colours depict homologous regions

Summary of Actinobacillus suis genomes included in in silico analyses BioProject ID PRJNA792721. Average nucleotide identity (%) between clinical (this study) and publicly available Actinobacillus suis genomes Multiple genome alignment across all strains used in this study. Blocks with the same colours depict homologous regions Phylogenetic analysis (Figure 2a) revealed two groups, one composed of the A. suis strains, markedly separated from the A. pleuropneumoniae NCTC 10976 strain. When investigating the A. suis strains only (Figure 2b), western Canadian isolates obtained from lungs clustered together; they were found closely related to the three reference isolates recovered two decades ago (H91‐0406, H89‐1173, H91‐038) from Ontario, Canada, two of which were also obtained from lungs samples.
FIGURE 2

Phylogenetic relationship of Actinobacillus suis strains identified in this study (n = 9) and publicly available strains (n = 7) in relation to a Actinobacillus pleuropneumoniae reference strain (a) and the A. suis strains only (b). Trees were constructed using RAxML program by comparing 500 randomly selected genes. Organ from which isolates were obtained are coded by colour (lung: blue; heart: orange; blood: red; brain: green). Shapes indicated geographical origin of each isolate (circle: Manitoba, Canada; square: Ontario, Canada; triangle: USA; diamond: Brazil; rectangle: UK)

Phylogenetic relationship of Actinobacillus suis strains identified in this study (n = 9) and publicly available strains (n = 7) in relation to a Actinobacillus pleuropneumoniae reference strain (a) and the A. suis strains only (b). Trees were constructed using RAxML program by comparing 500 randomly selected genes. Organ from which isolates were obtained are coded by colour (lung: blue; heart: orange; blood: red; brain: green). Shapes indicated geographical origin of each isolate (circle: Manitoba, Canada; square: Ontario, Canada; triangle: USA; diamond: Brazil; rectangle: UK) While European and USA isolates clustered separately from Canadian A. suis isolates, the position of the South American strain AS108/13 is unclear. This strain clustered separately or within the Canadian cluster depending on the phylogenetic reconstruction (Figure 2a,b), sometimes with low bootstrap values. Genome sequences from other South American strains will be necessary to clarify the interrelationship between A. suis of the different geographic regions. Proteome analysis revealed that most proteins encoded were greater than 99% similar to the reference genomes. However, a few sections with only 20%–70% identity were also identified in all genomes (Figure 3). Genomic gaps in four of nine and seven of nine western Canadian strains, when compared to the reference strain, were identified at 1.0 and 2.5 Mbp regions, respectively. The complete list of protein sequences with less than 70% similarity and gaps where proteins were only identified in ATCC 33415 are provided in Supporting Information S1. In all genomes, five predicted proteins were identified with less than 70% similarity: long‐chain fatty acid transport protein, Cu(l)‐responsive transcriptional regulator, lead, cadmium, zinc and mercury‐transporting ATPase, cell division proteins FtsP and CopG (copper reductase). Strains 20_277_1a, 20_377_1a and 4286 were the only strains with less than 70% similarity to ATCC 33415 KptS gene (capsular polysaccharide ABC transporter). This region also contained a tyrosine recombinase, usually involved in chromosomal integration of mobile genetic elements.
FIGURE 3

Circle plot depicting protein sequence homology between nine clinical Actinobacillus suis isolates relative to the reference strain ATCC 33415

Circle plot depicting protein sequence homology between nine clinical Actinobacillus suis isolates relative to the reference strain ATCC 33415 Putative virulence genes were identified in all western Canadian strains (Table 5). Noteworthy, strains 20_277_1a and 20_377_1a, which were isolated from heart and brain samples, carried more RTX‐associated genes (n = 9) than all other strains (including ATCC 33415 and all other strains isolated from lung samples). Antimicrobial resistance genes were identified only in western Canadian strains 20_277_1a and 20_377_1a, which had an ARG profile similar to the publicly available genomes (Table 6). The exception was strain AS108/13 that harboured more ARG genes than all other strains, in a unique profile that may be related to the presence of the unique genome regions mentioned above.
TABLE 5

Virulence‐associated genes

Virulence factorsReferenceATCC 3341520_277_1a20_377_1a17_471428619_41919_41819_29818_46618_292H91‐0380H91‐0406H89‐1173NCTC 12996ATCC 15557AS108/13
Source organBloodHeartBrainLungLungLungLungHeartLungLungLungLungBloodBloodLung
Autotransporters42813118777986888888
Outer membrane proteins4213121212121212121212131212131213
Filamentous haemagglutinin422741111111211222
Sialic acid442222222222222222
Lipopolysaccharides447997777777777777
Biofilm194564444544444444
Iron acquisition4528343528282828282828282828282828
Repeat in toxins108994444444444844
TABLE 6

Antibiotic resistance genes in clinical Actinobacillus suis strains obtained in this study

Strain IDResistance genes (>80% identity)
20_277_1aEF‐Tu
20_377_1aEF‐Tu
19_419None
19_418None
17_471None
4286None
18_292None
18_466None
19_298None
ATCC 33415EF‐Tu
ATCC 15557EF‐Tu
H89‐1173EF‐Tu
H91‐0380EF‐Tu
H91‐0406EF‐Tu
NCTC 12996EF‐Tu
AS108/13ROB‐10, Tet(H), APH(3″)‐IB, APH(6)‐Id, Sul2, EF‐Tu

Abbreviations: APH(3″)‐IB, aminoglycoside; APH(6)‐Id, aminoglycoside; EF‐Tu, Escherichia coli EF‐Tu mutants conferring resistance to pulvomycin/elfamycin class; ROB‐10, cephalosporin, penam; Sul2, sulphonamide; Tet(H), tetracyclines.

Virulence‐associated genes Antibiotic resistance genes in clinical Actinobacillus suis strains obtained in this study Abbreviations: APH(3″)‐IB, aminoglycoside; APH(6)‐Id, aminoglycoside; EF‐Tu, Escherichia coli EF‐Tu mutants conferring resistance to pulvomycin/elfamycin class; ROB‐10, cephalosporin, penam; Sul2, sulphonamide; Tet(H), tetracyclines.

DISCUSSION

In this study, we showed that A. suis isolates obtained from organs without a mucosal surface harboured an increased number of RTX toxin genes, a potential disease determinant in A. suis. We also observed that clinical A. suis strains circulating in Canadian commercial herds between 2018 and 2019 were phylogenetically similar to those characterised in the late 1900s. Taken together, these findings reiterate the importance of A. suis surveillance to prevent the introduction of new strains and sheds a light on potential markers of virulence. RTX toxins are widespread in the Actinobacillus genus. These toxins have haemolytic, cytotoxic and cytolytic activity; they can induce the production of inflammatory mediators, thereby leading to necrosis in host tissue. In this study, we found an increased number of RTX‐coding genes in isolates obtained from theoretically sterile organs. In yeast, an increased number of gene copies resulted in increased protein production. When yeasts were grown under stress, such as glucose‐deprived environment, cells with multiple gene copies associated with glucose metabolism were selected and thrived in that environment. , In addition, E. coli and Streptococcus pneumoniae strains, with increased antimicrobial resistance gene copies, show increased phenotypic resistance to specific drugs. , Gene copy number change is a phenomenon established as part of adaptation and evolution of bacteria. RTX toxins are suggested as disease determinants in A. suis. Previous reports investigating the A. suis genomes have reported a maximum of seven RTX gene copies per genome, but no correlation with clinical findings was performed. We postulate that strains with increased RTX copies may more efficiently colonise non‐mucosal tissues (such as blood) reaching immune‐privileged organs, leading to increased pathogenicity. Given the small number of strains with an increased number of RTX gene copies identified in this study, it remains to be verified if this change truly is associated with increased virulence. Further research focused on evaluating this change using animal models may help clarify this question. Several other virulence factors, such as lipopolysaccharides (LPS), capsular polysaccharides, proteins associated with iron chelation and cellular adhesion also play a role in A. suis pathogenesis. , Changes in the LPS structure also appear to be associated with the range of virulence observed in different A. suis strains. Adhesins facilitate bacterial colonisation and biofilm formation, including the adhesion of other bacteria. Finally, this bacterium also carries receptors that recognise and bind to haemoglobin‐bound iron, transferring it to the bacterial cytoplasm. Despite decades between the isolation of the strains obtained in this study and some of those publicly available, withstanding the exposure to antibiotics used for pork production, we found limited evidence of major changes to the gene content of A. suis isolated from diseased pigs. In fact, some of the current strains were phylogenetically very similar those isolated in the last century, with a high nucleotide similarity score. Limited genomic fragment insertions were identified in the western Canadian strains and the gene order identified was the same. It has been established that the genome structure of bacteria can change slowly with time due to local or global mutations. , , Treatment and control of A. suis is usually achieved through antimicrobial therapy, often based on ceftiofur, gentamicin and trimethoprim/sulphadiazine, ampicillin, sulphadimethoxine or tiamulin. Interestingly, we did not identify ARG related to any drugs used in pork production in the western Canadian strains. The only strain harbouring ARG for β‐lactams, sulphadiazine and sulphadimethoxine was AS108/13. One caveat in this analysis was the lack of phenotypic antimicrobial susceptibility data. While future investigations should focus on evaluating the efficacy of A. suis whole genome sequencing in predicting resistance patterns, it has been shown to be highly correlated to phenotypical resistance results for other bacterial species. Despite this, we did identify nucleotides changes in the gene coding for the copper resistance protein CopG present in the western Canadian strains, when compared to the ATCC 33415 reference strain. CopG encodes a 14 kDa periplasmic protein that is suggested to contribute to copper resistance by reducing free copper ions. This protein is widely spread across Gram‐negative bacterial species; genes encoding CopG homologues are often found associated with other known metalloproteins. One study proposed that CopG is the main copper detoxification mechanism employed by Vibrio cholerae when under anaerobic conditions. Future research may further explore how the changes identified in the western Canadian strains contribute to the biological activity of CopG. Actinobacillus suis remains a challenge for swine production. As the livestock industry moves towards a reduction in overall antimicrobial usage, it is likely that this agent will become more relevant in the coming years. Here, we have shown that isolates obtained from brain and heart had more RTX toxin gene copies in their genomes than those isolated from lungs. We have shown that A. suis recently circulating in commercial farms in Canada are similar to isolates from 1990 to 2000s. Antimicrobial resistance genes detected in clinical isolates suggest the potential for resistance to drugs of importance to human medicine.

AUTHOR CONTRIBUTIONS

Matheus de Oliveira Costa acquired funding and conceptualised the study. Matheus de Oliveira Costa, Dharmasiri Gamage Ruwini Sulochana Kulathunga and Alaa Abou Fakher performed the analyses. Dharmasiri Gamage Ruwini Sulochana Kulathunga drafted the first version of the manuscript. Matheus de Oliveira Costa reviewed the manuscript and the data analyses.

CONFLICTS OF INTEREST

The authors declare they have no conflicts of interest.

ETHICS STATEMENT

No ethical approval was required because the work did not directly use any live pigs. Supporting information Click here for additional data file. Supporting information Click here for additional data file.
  36 in total

Review 1.  Agents of the "suis-ide diseases" of swine: Actinobacillus suis, Haemophilus parasuis, and Streptococcus suis.

Authors:  J I MacInnes; R Desrosiers
Journal:  Can J Vet Res       Date:  1999-04       Impact factor: 1.310

2.  Actinobacillus suis infection in pigs in Australia.

Authors:  R J Wilson; S McOrist
Journal:  Aust Vet J       Date:  2000-05       Impact factor: 1.281

3.  Actinobacillus suis, a potential cause of abortion in gilts and low parity sows.

Authors:  C Mauch; G Bilkei
Journal:  Vet J       Date:  2004-09       Impact factor: 2.688

4.  An outbreak of Actinobacillus suis septicemia in grow/finish pigs.

Authors:  M J Yaeger
Journal:  J Vet Diagn Invest       Date:  1996-07       Impact factor: 1.279

5.  Comparative pathogenicity of different Actinobacillus suis O/K serotypes.

Authors:  D Slavić; J DeLay; M A Hayes; J I MacInnes
Journal:  Can J Vet Res       Date:  2000-04       Impact factor: 1.310

6.  A fast algorithm for the multiple genome rearrangement problem with weighted reversals and transpositions.

Authors:  Martin Bader; Mohamed I Abouelhoda; Enno Ohlebusch
Journal:  BMC Bioinformatics       Date:  2008-12-04       Impact factor: 3.169

7.  Actinobacillus suis infection in pigs in southwestern Ontario.

Authors:  S E Sanford; G K Josephson; A J Rehmtulla; A M Tilker
Journal:  Can Vet J       Date:  1990-06       Impact factor: 1.008

8.  New implications on genomic adaptation derived from the Helicobacter pylori genome comparison.

Authors:  Edgar Eduardo Lara-Ramírez; Aldo Segura-Cabrera; Xianwu Guo; Gongxin Yu; Carlos Armando García-Pérez; Mario A Rodríguez-Pérez
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

9.  Draft Genome Sequences of Six Actinobacillus pleuropneumoniae Serotype 8 Brazilian Clinical Isolates: Insight into New Applications.

Authors:  Monalessa Fábia Pereira; Ciro César Rossi; Fabíola Marques de Carvalho; Luiz Gonzaga Paula de Almeida; Rangel Celso Souza; Ana Tereza Ribeiro de Vasconcelos; Denise Mara Soares Bazzolli
Journal:  Genome Announc       Date:  2015-03-05

10.  Improvements to PATRIC, the all-bacterial Bioinformatics Database and Analysis Resource Center.

Authors:  Alice R Wattam; James J Davis; Rida Assaf; Sébastien Boisvert; Thomas Brettin; Christopher Bun; Neal Conrad; Emily M Dietrich; Terry Disz; Joseph L Gabbard; Svetlana Gerdes; Christopher S Henry; Ronald W Kenyon; Dustin Machi; Chunhong Mao; Eric K Nordberg; Gary J Olsen; Daniel E Murphy-Olson; Robert Olson; Ross Overbeek; Bruce Parrello; Gordon D Pusch; Maulik Shukla; Veronika Vonstein; Andrew Warren; Fangfang Xia; Hyunseung Yoo; Rick L Stevens
Journal:  Nucleic Acids Res       Date:  2016-11-29       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.